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Updating JPROT's publication standards for large-scale
proteomic studies: Towards hypothesis-driven interpretation
of predictive biological modelsThe development in the 1990s of biological mass spec-
trometry into a robust analytical tool heralded a paradigm shift
in biological research. Advances in instrumentation and
methodologies have since fueled an expansion of the scope of
biologicalmass spectrometry, from the simple analysis of single
proteins to the characterization of highly complex proteomes.
The cornerstone of proteomics analysis is the simultaneous
identification and quantitation of the protein components of
biological systems using increasingly sophisticated and sensi-
tive mass analyzers; its beast, data validation and the interpre-
tation of large-scale experiments. Data validation represents an
essential step for ensuring independent repeatability and
replication of the experiment by other researchers. However,
the toughest aspect of proteomics studies is the interpretation
in ameaningful biological context of both limited 2DE gel-based
protein maps and large (gel-free, high-throughput) datasets.
Around the turn of the new century, proteomics began moving
from a purely descriptive mode to quantitative methods. The
throughput of proteomics measurements depends on the level
of detail desired. Paradoxically, the increased capabilities of
mass spectrometry have led to proteomics increasingly func-
tioning as a ‘black box’ [1]. However, with thousands of genomes
sequenced to date, and many other in progress, the goal for the
proteomics community now is to show how the ‘parts-list’ of a
complex proteome provides a valuable asset for hypothesis-
driven research in biological sciences. The central thesis of this
Editorial, developed below, is that validation and interpretation
become unified through the formulation of an adequate testable
biological hypothesis. A corollary of this statement is that
making biological sense of a proteomics experiment requires a
paradigm shift in both experimental design and publication
policy of biological mass spectrometric data. There is a lack of
conformity among proteomics journals about publication
standards for proteomics studies, and this is certainly not a
trivial matter. Proteomics is applied to investigate a wide range
of biological systems, both model (genome sequence available)
and non-model organisms, and each study requires a somehow
different experimental approach. Although high-quality re-
search on non-model organisms, as well as papers describing1874-3919 © 2012 Elsevier B.V.
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and proteomics, will continue to be welcome in the pages of
Journal of Proteomics, this journal will implement in the Instructions
for Authors the requirement for original papers to include a
paragraph (“Significance”) describing how the reported method-
ology or proteomics findings significantly advance, respectively,
the field and the understanding of the biological process
investigated. In addition, authors of studies onmodel organisms
are encouraged to interpret their proteomics data using pre-
dictive models. In the medium term this paradigm shift may
contribute to change the Linnean taxonomic concept of reporting
large collections of proteomics data by a hypothesis-driven
approach of elucidating molecular pathways and biological
mechanisms.
A key argument for the shift in editorial policy emerges
from a reflection on how the information encoded in mass
spectra is transformed into a relevant biological output. Mass
spectrometry has a long history of use as a standard tech-
nique for the structural elucidation of nonpeptidic small
molecules with a molecular mass less than 2000 Da [2]. The
success of structure elucidation of these small molecules lies
in the evaluation of high-resolution and accurate multiple-
stage (MSn) mass spectral data based on fragmentation rules
rooted in the era of electron ionization mass spectrometry
from the 1970s and 1980s (reviewed in [2]), the availability of
fragmentation mass spectra libraries from known compounds,
and expert computer-aid systems for mass spectral interpreta-
tion. Spectral information represents also the Rosetta Stone
strategy for deciphering the proteomics experiment. Further,
whereas de novo structure elucidation of small molecules by
MS is challenging due to the high molecular diversity of struc-
tures and fragmentation pathways, including rearrangement
reactions, homolytic or heterolytic bond cleavages, hydrogen
rearrangements, electron shifts, resonance reactions, and aro-
matic stabilizations, peptides yield significantly simpler and
reliable array of fragment ions [3,4]. Hence, arguably granted,
given human or computational skills to decipher it, an MS/MS
spectrum containing the complete set of sequence-specific
and satellite fragment ions offers sufficient resolution to
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However, assessment of each individual spectrum recorded
in high-throughput proteomics measurements is nearly im-
practical, even for an experienced mass spectrometrist, and an
accurate and complete computerized interpretation of fragmen-
tation spectra is far from being a routine application [5]. On the
other hand, due to a trade-off between data acquisition speed
and spectral quality, most automatically acquired LC-MS/MS
spectra, particularly those produced in the limited time of duty
cycles of high-throughput or shotgun experiments, do not
encode unbroken series of fragment ions; there are gaps and
ambiguities and thus decoding the information contained in a
partial fragmentation spectrum into a sequence tag requires
data reconstruction through probabilistic inference. A major
challenge of this approach involves ranking the collection of
compatible peptide matches through the assignment of statis-
tical confidence scores that quantify the agreement between
observed and predicted data. A significantly high protein score,
based on the calculated probability that the observed match
between the experimental data and the database sequence is
not random, minimizes the number of false positives. However,
even the best scoring scheme cannot fully separate the correct
and incorrect matches [6]. To circumvent this weakness, a
commonly employed strategy to validate probabilistically-
assigned matches is the verification of the candidate proteins
using independent evidence. As in Schrödinger's cat paradox,
orthogonal verification produces the collapse of the assigned
probability into a defined state. However, for 2DE and large-
scale proteomics workflows the non-observed proteome is
often larger than the observed dataset, and data validation per
se does not contribute to increase the information content, and
thus the biological value, of the observed proteome. On the
other hand, the interpretation of the proteomics dataset in a
meaningful biological context is critically dependent on the
available information. This vicious circle can be opened by
verifying predictions based on a model originally generated
from the reduced set of experimentally observed data. Each
prediction-verification step transfers information from the
non-observed to the observed proteomics set, contributing
thereby to garner greater amounts of information and thus to
a more plausible interpretation of the experiment. The center-
piece of this iterative procedure is the predictive ability of the
biological hypothesis. In analogy with particle physics, the
hypothesis represents the boson that, through experimental
contrasting of its predictions, provides an opportunity to assess
the consistency of the proposed model endowing biological
meaning to the proteomics data. Hypothesis-driven validation
bears the repercussion of reducing the complexity of large-scale
datasets and the impact of individual false positives through
the recognition of biological trends. Amajor challenge ofmodel
validation is the achievement of an accurate match between
model predictions and the experimental data. In this regard,
methodologies such as targeted proteome investigation via
selected reaction monitoring mass spectrometry [7] may be-
come increasingly important for validating hypothesis-driven
model predictions.
Sharing the fruits of research is critically important to
the advancement of biological sciences, and there are strong
moves towards standards and guidelines for the exchange
and publication of proteomics data. The Human ProteomeOrganization's Proteomics Standards Initiative (http://www.
psidev.info/) is very active in this area. From its launch, Journal
of Proteomics has supported the Proteomics Standards Initiative
to develop guidance modules for reporting the use of basic
techniques commonly employed in a proteomics workflow
[8]. Journal of Proteomics also follows with great interest and
expectations the development of appropriate databases for
information sharing, mining and extracting. A few proto-
type repositories for proteomics data are starting to get off
the ground (i.e. PRIDE, http://www.ebi.ac.uk/pride/), but their
structural complexity and lack of appropriate tools still make
almost impossible the recovery of valuable knowledge from
those sites and thus the possibility of generating hypothesis
based on the raw data and associated metadata deposited by
other researchers. Authors submitting their work to J. Proteomics
will be asked to provide access to raw MS data through public
databases as they emerge.Meanwhile, data depositionwill only
be mandatory upon requirement of the editors or reviewers.
Genome databases, such as NCBI (http://www.ncbi.nlm.
nih.gov) or GOLD (http://www.genomesonline.org), contain
sequence and map data from the whole genomes of several
thousands of organisms representing all three domains of
life (bacteria, archaea, and eukaryota). Of particular relevance
would thus be the development of software to integrate
proteomics data gathered on these model organisms into the
spectrum of other “omics” data to create metadata structures
from which predictive biological models could be generated.
Updating Journal of Proteomics' guidelines for publishing proteo-
mic studies of model organisms pursues this goal.R E F E R E N C E S
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